FRIED ROBERT N (CEO) received a stock award from NIAGEN BIOSCIENCE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/8/2026ACC: 0001417952-26-000002
DirectorOfficer· CEO
Since Nov 2018
+1.11K
Net shares
Net buyer
$3.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.11K
Price / share
$2.71
Trade value
$3K
% of position
0.1%
6/30/2026
1.06M→1.06M
Total
Net shares
+1.11K
Net value
$3K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | A · Award | +1.11K | $2.71 | $3K | 0.1% | 1.06M | 1.06M |
| Total | +1.11K | $3K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned95K
Common Stock
IndirectShares owned250K
Common Stock
IndirectShares owned250K
Common Stock
IndirectShares owned12.75K
Total
607.75K indirect607.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 95K | Indirect |
| Common Stock | 250K | Indirect |
| Common Stock | 250K | Indirect |
| Common Stock | 12.75K | Indirect |
| Total | 607.75K | 607.75K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported